Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis-Reference-Cited by-同舟云学术

Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis

Published:2007-12-14 Issue:2 Volume:21 Page:96-104
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Kartha Reena V,Sundram Uma N

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800980.pdf

Reference49 articles.

1. Agelli M, Clegg LX . Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003;49:832–841.

2. Goepfert H, Remmler D, Silva E, et al. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol 1984;110:707–712.

3. Allen PJ, Zhang ZF, Coit DG . Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97–105.

4. Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300–2309.

5. Manor E, Bellaiche E, Bodner L . Cytogenetic findings of a primary Merkel cell carcinoma. Cancer Genet Cytogenet 2006;169:78–80.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutational analysis of PDGFRA oncogene in high-grade neuroendocrine carcinoma of the uterine cervix in twelve Taiwanese women;Taiwanese Journal of Obstetrics and Gynecology;2024-01

2. Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes;JNCI: Journal of the National Cancer Institute;2022-04-27

3. Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies;International Journal of Molecular Sciences;2021-06-11

4. Skin Neuroendocrine Neoplasms;The Spectrum of Neuroendocrine Neoplasia;2020-10-20

5. Merkel Cell Carcinoma – Current Controversies and Future Directions;Clinical Oncology;2019-11